Sentinel node-positivt melanom

Mette Haldrup; Lars B Stolle; Lisbeth Rosenkrantz Hölmich; Annette Chakera

Sentinel node-positivt melanom

Translated title of the contribution: Sentinel node-positive melanoma

Mette Haldrup, Lars B Stolle, Lisbeth Rosenkrantz Hölmich, Annette Chakera

Department of Clinical Medicine

Abstract

Two recent randomised studies found no survival difference in patients, who had melanoma with metastasis to the sentinel node (SN) and underwent immediate complete lymph node dissection (CLND), compared with patients, who were followed closely with ultrasound scans and only underwent CLND if metastases developed. From 2018, the Danish guidelines concur: SN-positive patients will no longer undergo routine CLND, which has high morbidity, but will be followed with ultrasound scans of the SN-positive region(s) at their follow-up visits every third month for two years, then every six month for three years, except if PET-CT is performed.

Translated title of the contribution	Sentinel node-positive melanoma
Original language	Danish
Article number	V03180192
Journal	Ugeskrift for Laeger
Volume	180
Issue number	41
Number of pages	4
ISSN	0041-5782
Publication status	Published - 8 Oct 2018

Access to Document

http://ugeskriftet.dk/videnskab/sentinel-node-positivt-melanom

Cite this

@article{7663dc4efce1446bb86e9ae2e16d9b2e,

title = "Sentinel node-positivt melanom",

abstract = "Two recent randomised studies found no survival difference in patients, who had melanoma with metastasis to the sentinel node (SN) and underwent immediate complete lymph node dissection (CLND), compared with patients, who were followed closely with ultrasound scans and only underwent CLND if metastases developed. From 2018, the Danish guidelines concur: SN-positive patients will no longer undergo routine CLND, which has high morbidity, but will be followed with ultrasound scans of the SN-positive region(s) at their follow-up visits every third month for two years, then every six month for three years, except if PET-CT is performed.",

author = "Mette Haldrup and Stolle, {Lars B} and H{\"o}lmich, {Lisbeth Rosenkrantz} and Annette Chakera",

year = "2018",

month = oct,

day = "8",

language = "Dansk",

volume = "180",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "41",

}

TY - JOUR

T1 - Sentinel node-positivt melanom

AU - Haldrup, Mette

AU - Stolle, Lars B

AU - Hölmich, Lisbeth Rosenkrantz

AU - Chakera, Annette

PY - 2018/10/8

Y1 - 2018/10/8

N2 - Two recent randomised studies found no survival difference in patients, who had melanoma with metastasis to the sentinel node (SN) and underwent immediate complete lymph node dissection (CLND), compared with patients, who were followed closely with ultrasound scans and only underwent CLND if metastases developed. From 2018, the Danish guidelines concur: SN-positive patients will no longer undergo routine CLND, which has high morbidity, but will be followed with ultrasound scans of the SN-positive region(s) at their follow-up visits every third month for two years, then every six month for three years, except if PET-CT is performed.

AB - Two recent randomised studies found no survival difference in patients, who had melanoma with metastasis to the sentinel node (SN) and underwent immediate complete lymph node dissection (CLND), compared with patients, who were followed closely with ultrasound scans and only underwent CLND if metastases developed. From 2018, the Danish guidelines concur: SN-positive patients will no longer undergo routine CLND, which has high morbidity, but will be followed with ultrasound scans of the SN-positive region(s) at their follow-up visits every third month for two years, then every six month for three years, except if PET-CT is performed.

M3 - Tidsskriftartikel

C2 - 30327078

SN - 0041-5782

VL - 180

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 41

M1 - V03180192

ER -

Sentinel node-positivt melanom

Abstract

Access to Document

Fingerprint

Cite this